Big Pharma says vaccine patent waiver sets dangerous precedent

Waiving patent protections for COVID-19 vaccines is fiercely opposed by Big Pharma because they say it would set a precedent that could threaten future innovations, and insist the move would not speed up production.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.